Treatment Protocol of Replagal for Patients With Fabry Disease
Public ClinicalTrials.gov record NCT01031173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Treatment Protocol to Evaluate the Safety of Replagal Treatment in Patients With Fabry Disease.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the safety and efficacy of Replagal® (agalsidase alfa) at a dose of 0.2 mg/kg infused intravenously (IV) over 40 minutes, every other week. The study will monitor the course of disease in males and females with Fabry disease who are naive to treatment or were previously treated with agalsidase beta (Fabrazyme®).
Study identification
- NCT ID
- NCT01031173
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- May 24, 2021
United States locations
- U.S. sites
- 25
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AKDHC Tucson Campbell | Tucson | Arizona | 85718 | — |
| University of California San Diego Medical Center | La Jolla | California | 92093-0830 | — |
| Kaiser Medical Group Southern CA, Regional Metabolic Services | Los Angeles | California | 90027 | — |
| Children's Hospital & Research Center Oakland | Oakland | California | 94609 | — |
| UC Davis Children's Hospital | Sacramento | California | 95817 | — |
| Central Coast Nephrology | Salinas | California | 93901 | — |
| Denver Nephrologists, PC | Denver | Colorado | 80230 | — |
| University Research Foundation for Lysosomal Storage Disorders | Coral Springs | Florida | 33065 | — |
| Stuart Oncology Associates | Stuart | Florida | 34994 | — |
| Emory University School of Medicine | Decatur | Georgia | 30033 | — |
| Emory University | Decatur | Georgia | 30033 | — |
| University of Iowa Health Center | Iowa City | Iowa | 52242 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| Infusion Associates | Grand Rapids | Michigan | 49525 | — |
| University of Missouri Healthcare | Columbia | Missouri | 65212 | — |
| St. Joseph's Regional Medical Center | Paterson | New Jersey | 07503 | — |
| North Shore Hematology/Oncology | Manhasset | New York | 11030 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| Fullerton Genetics Center-Mission, St. Joseph's Hospital | Asheville | North Carolina | 28803 | — |
| The Toledo Hospital | Toledo | Ohio | 43606 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Tidewater Kidney Specialists | Chesapeake | Virginia | 23320 | — |
| Carilion New River Valley Medical Center | Christiansburg | Virginia | 24073 | — |
| O & O Alpan LLC | Springfield | Virginia | 22152 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01031173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01031173 live on ClinicalTrials.gov.